首页> 美国卫生研究院文献>Science and Technology of Advanced Materials >Polyurethane/polycaprolactone membrane grafted with conjugated linoleic acid for artificial vascular graft application
【2h】

Polyurethane/polycaprolactone membrane grafted with conjugated linoleic acid for artificial vascular graft application

机译:共轭亚油酸接枝的聚氨酯/聚己内酯膜在人工血管移植中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Constructing satisfied small-diameter vascular graft (diameter less than 6 mm) remains an unsolvable challenge in vascular tissue engineering. This study described the fabrication of electrospun polyurethane/polycaprolactone (PU/PCL) membranes chemically grafted with various densities of conjugated linoleic acid (CLA) – an antithrombotic fatty acid – for making small-diameter blood vessel. Differences in mechanical, antithrombotic properties and biocompatibility of the membranes resulting from the CLA-grafting procedure were the focus of the study. Investigation of mechanical properties relevant to vascular graft application revealed that these properties of the membranes remained unaffected and satisfied clinical criteria following the CLA graft. Blood–membrane interaction assays showed that the CLA-grafted membranes mitigated the adhesion of blood cells, as well as preventing blood coagulation. These effects were also commensurate with increasing density of CLA, suggesting an effective approach to improve antithromboticity. Cellular tests suggested that CLA has an optimal density at which it promoted cell proliferation on the surface of the membranes; however, excessive presence of CLA might cause undesirable inhibition on cells. In conclusion, PU/PCL membrane grafted with CLA could be a prospective material for vascular tissue engineering with further development and investigation.
机译:在血管组织工程中,构建令人满意的小直径血管移植物(直径小于6毫米)仍然是无法解决的挑战。这项研究描述了电纺聚氨酯/聚己内酯(PU / PCL)膜的制造方法,该膜化学接枝了各种密度的共轭亚油酸(CLA)(一种抗血栓形成的脂肪酸),用于制造小直径血管。 CLA接枝过程导致的膜的机械,抗血栓性质和生物相容性差异是研究的重点。对与血管移植物应用有关的机械性能的研究表明,在CLA移植后,这些膜的性能仍然不受影响,并满足临床标准。血膜相互作用测定表明,CLA移植的膜减轻了血细胞的粘附,并防止了血液凝固。这些作用还与CLA密度的增加相对应,表明改善抗血栓形成性的有效方法。细胞试验表明,CLA具有最佳密度,可以促进膜表面细胞的增殖。但是,过量存在的CLA可能会对细胞产生不良抑制作用。总之,随着CLA移植的PU / PCL膜可以作为血管组织工程的前瞻性材料,并有进一步的开发和研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号